Prizes & Awards

  • 2021

Force'Partners prize. Public Prize force'awards Hauts-de-France to Willand, N. (Nov 2021) promotion of partnerships between academic research and companies and candidates with remarkable innovative projects in the 'Hauts-de-France' region

'Insigne des amis de la légion d'honneur' to Brier, L. (Oct 2021) Engagement of less than 30s to covid19 fight
  • 2020

5th Drug Discovery Day Best Oral Communication Prize  to Brier, L. (Dec 2020) Discovery of new inhibitors of the SARS-CoV-2 3CL protease by High Throughput Screening. Lille, France.

5th Drug Discovery Day Best Poster Prize to Kraupner, N. (Dec 2020) PROTAC® an emerging drug discovery technology for target validation.  Lille, France.

2020 Michel Delalande Prize of the Academie Nationale de Pharmacie to R. Deprez-Poulain (Dec. 2020).

27th YRFM of the SCT, Best Poster Prize to Abdesselam, T. (Janv 2020) Modulations of a piperidine-based hit identified from a phenotypic-screening, for the treatment of tuberculosis. Caen, France.

  • 2019

4th Drug Discovery Day Best Oral Communciation Prize to Camberlein, V. (Dec 2019) Discovery of hERAP2 inhibitors by in situ click chemistry.  Lille, France.

4th Drug Discovery Day Best Poster Prize to Abdesselam, T. (Dec 2019) Modulations of a piperidine-based hit identified from a phenotypic-screening, for the treatment of tuberculosis. Lille, France.

2019 Drug Discovery Day, Best Poster Prize to Andres, M.  (Jan 2019) New insights into a potential therapeutic target regulating Unfolded Protein Response and subsequent inflammation in liver and muscle. Lille, France

  • 2018

25th YRFM of the SCT. Best Poster Prize (Elsevier). to Faion, L. (Fev 2018) Chemical modifications of Mycobacterium tuberculosis MabA inhibitors. , Orleans, France

  • 2017

Pierre Fabre Innovation Award from SCT. to Deprez, B, Toulouse, France, (Jul 2017).

24th YRFM of the SCT, Best Poster presentation.  to Hoguet, V., (Feb 2017), Development of new topical intestinal agonists of the bile acid receptor TGR5 for the treatment of type 2 diabetes, Châtenay-Malabry, France,

1st Forum Recherche.Best Poster Prize.   to Hoguet, V. (Jul 2017) Development of new topical intestinal agonists of the bile acid receptor TGR5 for the treatment of type 2 diabetes, School of Pharmacy, Lille, France.

24th YRFM of the SCT, Best Poster Communication to Hoguet, V. (Feb 2017) Development of new topical intestinal agonists of the bile acid receptor TGR5 for the treatment of type 2 diabetes, Châtenay-Malabry, France.

  • 2016

23rd YRFM of the SCT, Best Oral Communication, (Feb 2016) to Prevet, H. New 3D-scaffolds for Fragment-based Lead Discovery: exploration of chemical space using highly functionalized spirohydantoins, Lille, France.

23rd YRFM of the SCT, Best Poster Communication, (Feb 2016) Pintiala, C. Development of synthetic pathways to access propiolic acids as fragments for drug discovery, Lille, France

  • 2015

Institut Universitaire de France, Junior Member to Deprez-Poulain, R., 2015-2020.

22nd YRFM of the SCT, Best Oral Communication,
(Mar 2015) to Lasalle, M. Design of agonists of the bile acid receptor TGR5, Biocitech, Romainville, France.

  • 2014

14th Journées André Verbert (Sep 2014), Best oral communication to Lasalle, M., Lille France.

1st of Regional Famelab Selection (Mar 2014) to Lasalle, M. Recepteurs intestinaux aux nutriments: interaction diabète et nutrition Villeneuve d'Ascq, France

21st Young Research Fellow Meeting of the SCT, Best Flash Presentation (Mar 2014) to Prevet, H. Montpellier, France.

  • 2013

RICT-2013, Best Poster Prize (Jul 2013) to Damien Bosc. Discovery via in situ click chemistry and structure activity relationships of inhibitors of Insulin-Degrading Enzyme, Nice, France.

  • 2012

RICT-2012, Best Poster Prize (Jul 2012) to Aurelia Dinut. Boosting Ethionamide by targeting the transcriptional repressor EthR. An emerging approach in tuberculosis drug development, Poitiers, France.

SCT Prix d'Encouragement à la Recherche 2011- SCT/Servier (Mar 2012) to Nicolas Willand, Paris, France.

  • 2011

MedChem Poster Prize (Nov. 2011) to Baptiste Villemagne, B. Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV: Emerging Targets and Treatments: Opportunities and Challenges for Drug Design, Ghent, Belgium.

Prize for medicinal chemistry vocation (Servier Poster prize) (Jul. 2011) Villemagne, B. RICT Drug Discovery and Selection, 47th International Conference on Medicinal Chemistry, Lyon, France.

SCT Jeunes Chercheurs Poster Prize (Feb. 2011) to Baptiste Villemagne. Design of EthR inhibitors as potent Ethionamide boosters using fragment based drug design (FBDD) approaches, Paris, France.

  • 2010

EFMC-ISMC 2010, Best Poster Prize (Sep. 2010) to Rebecca Deprez-Poulain. A New Concept For The Control Of Protease Activity : Substrate-Dependent Modulation, Brussels, Belgium.

Scientific Day PRIM. Lille Best Oral communication (Mar. 2010) to Baptiste Villemagne. Validation of a Fragment-Based Drug Design approach for the rapid discovery of EthR inhibitors: Growing strategy.

SCT Prix d'Encouragement à la Recherche 2009 - SCT/Servier (Mar 2010) to Rebecca Deprez-Poulain, Paris, France.

SCT Jeunes Chercheurs Poster Prize (Jan. 2010) to Mouhamad Jida. Utilisation de conditions microondes sans solvant pour la réaction de Meyers.

  • 2009

SBS 15th Annual Meeting Best Posters Prize (Apr. 2009) to Florence Leroux. Screening for Inhibitors of CD4-PLSCR1 Interaction, a New Target for Therapy of HIV-1 Infection.

SCT Jeunes Chercheurs Poster Prize (Jan. 2009) to Sandra Malaquin. Conception of protein-protein interactions inhibitors: screening and libraries synthesis.

TOP